-
In the Moment- Fall 2018
Tanya Waring-Hearn, Amy Rowley, Elsie Young.
-
Survivor Profile
The Power of PatientsJanet Freeman-Daily helps put patients at the center of lung cancer research.
by Robin Meadows
-
Raising Their Voices
People with metastatic breast cancer are demanding to be seen, counted and included in breast cancer research.
by Sue Rochman
-
Learning to Share
At first, I wanted to hide my cancer diagnosis. My son showed me what a mistake that was.
by Lenn Robbins
-
Being Candid About Cancer
As a father with an aggressive brain cancer, I've opted against elaborate metaphors and in favor of candid speech when talking about cancer with my children.
by Adam Hayden
-
Survivor Profile
A Long Road BackMultiple myeloma survivor Gary Lambert deploys inventiveness and fortitude to deal with cancer.
by Lindsey Konkel
-
In the Moment- Summer 2018
Jessica Melore, NJ DeVico, Steve Nolan, Rosemarie Rogers.
-
Advocacy Spotlight: Sorting Out Priorities
Ovarian cancer survivor and research advocate Annie Ellis is teaming up with researchers to better equip patients with recurrent cancer to make treatment decisions.
by Cici Zhang
-
In the Moment- Spring 2018
Kwesi Rollins, Jonathan Passley, Cameron Moon
-
Gaps in End-of-Life Care
Racial and ethnic backgrounds can be factors in whether cancer patients take advantage of hospice care. Researchers and clinicians are trying to understand the gaps and design strategies to bridge them.
by Charlotte Huff
Cancer Talk
Screening Options for People With Dense Breasts
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon